In the latest episode of our ‘Life sciences in the spotlight’ podcast series, Dr Pamela Walker, partner and life sciences lead at Gate One, speaks to James West, director of pharma services M&A at Lincoln International, about Covid-19 as a catalyst for M&A pharma activity.
Dr Pamela Walkerpamela.walker@gateoneconsulting.com
Pamela is a life sciences value creation, strategic growth and acquisition advisory specialist focused on delivering impressive outcomes for businesses, their employees and their customers. She has a PhD in medical sciences and an executive MBA (both from the University of Oxford). Her career spans drug development, strategy and management consulting within the global healthcare and pharmaceutical arenas.
Dr Pamela Walker
At Gate One, we tackle your toughest challenges and accelerate your boldest ambitions. Our mission is to deliver meaningful change.
